No. | SAPS II | Underlying conditions | Clinical syndrome/admission diagnosis | Type/source of infection | BG level (pg/mL)a | Antifungal treatment | Outcome | LOS ICU (days) |
---|---|---|---|---|---|---|---|---|
8 | 35 | Steroid therapy, solid cancer | Respiratory failure, severe sepsis | Candidemia/unknown | ≥500 | Caspofungin | Alive | 30 |
15 | 48 | Diabetes, obesity, chronic renal failure | Septic shock | Candidemia/UTI | ≥500 | Anidulafungin | Dead | 7 |
18 | 69 | Chronic renal failure, diabetes | Respiratory failure, septic shock | Mediastinitis/Unknown | ≥500 | Anidulafungin | Dead | 12 |
21 | 64 | COPD | Septic shock | Candidemia/unknown | ≥500 | Anidulafungin | Alive | 8 |
29 | 61 | Diabetes, chronic heart failure | Respiratory failure, severe sepsis | Candidemia/UTI | 480 | Anidulafungin | Dead | 92 |
32 | 67 | Chronic heart failure, solid cancer | Respiratory failure | Candidemia/CVC | 400 | Fluconazole | Alive | 26 |
35 | 45 | Hematological malignancy, diabetes | Septic shock | Candidemia/unknown | 255 | Anidulafungin | Dead | 7 |
51 | 65 | AIDS, cirrhosis | Septic shock, ALI | Candidemia/CVC | 322 | Caspofungin | Dead | 7 |
57b | 59 | Obesity, solid cancer | Respiratory failure, septic shock | Candidemia/CVC | 27 | Caspofungin | Dead | 14 |
60 | 39 | Renal transplant, steroid therapy | Trauma, severe sepsis | Candidemia/CVC | ≥500 | Caspofungin | Alive | 35 |
74 | 51 | Intestinal occlusion, chronic renal failure | Respiratory failure, severe sepsis | Candidemia/unknown | ≥500 | Anidulafingin | Alive | 65 |
79 | 26 | COPD, chronic hearth failure, diabetes | Septic shock, respiratory failure | Candidemia/CVC | ≥500 | Anidulafungin | Alive | 45 |
87 | 41 | Chronic hearth failure, COPD, diabetes, abdominal surgery | Severe sepsis, respiratory failure | Candidemia/UTI | ≥500 | Caspofungin | Alive | 45 |
89 | 30 | Chronic hearth failure, abdominal surgery, chronic renal failure | Septic shock | Candidemia/UTI | ≥500 | Caspofungin | Alive | 50 |